NICE (Nasdaq: NICE) today announced Interactions Live, the biggest customer experience virtual event of the year. To be held on September 15-16, this free event will provide unprecedented insights for adopting an agile service approach and creating extraordinary customer and employee experiences in any market dynamic. Featuring content to suit every role and interest, this global event offers a wealth of informative sessions, interactive demo stations, live video chats with NICE experts, exciting keynote speakers and entertaining performing artists. To learn more or register for the event, please click here.
Interactions Live will host Academy Award-Winning Actor, philanthropist and author of the upcoming book Greenlights, Matthew McConaughey as a keynote speaker, sharing his drive for constant reinvention throughout his impressive career spanning over 40 feature films that have grossed over $1 billion. Also keynoting will be Martha Stewart – Emmy Award-Winning television show host, bestselling author of 96 lifestyle books to date, entrepreneur and founder of the first multi-channel lifestyle company. The virtual event's analyst lineup includes McGee Smith, Forrester, DMG Consulting, Aberdeen, Everest Group and Saddletree Research who will review current industry trends and offer guidance on maintaining CX excellence in times of change. Also joining the event are industry-leading organizations who will discuss how they are innovating to provide agile service in the cloud, engage their workforce as they work remotely and leverage data insights to create exceptional experiences for customers and employees.
This year's event will include a virtual concert attendees can stream from any location, September 16 starting at 3:45 pm EST. It will feature Award-Winning musician, Bryan Adams who will take the stage to share his hits spanning four decades. One of the most exciting live musicians in the world, Bryan Adams' energetic performance, effortless stage presence and incredible vocals are guaranteed to thrill and entertain. Also joining is Award-Winning artist, Alanis Morissette, whose album, Jagged Little Pill remains the best-selling debut release by a female artist in the U.S. and the highest-selling debut album worldwide in music history.
With over seven tracks and more than 50 best practice sessions, the conference agenda is rich with ideas, insights and advice that will inspire, energize, and invigorate CX professionals of all ranks. Attendees can join informative best practices sessions, engage with various experts, see live demos of the latest innovations and be inspired by industry-leading customer speakers, visionary leaders and subject-matter-experts from prominent organizations.
Barak Eilam, CEO, NICE, said, "CX agility has never been more critical and we remain focused on helping organizations transform experiences to be extraordinary. In the face of the unprecedented current challenges organizations are facing, we aim to bring clarity by sharing powerful insights that will enable organizations to be agile in engaging customers and employees while driving successful business outcomes. Interactions has always been a key channel through which we connect among customers, content experts, innovators and opinion-makers, and we're pleased to present a new avenue to enable this connection via Interactions Live. "
About NICE NICE (Nasdaq: NICE) is the world’s leading provider of both cloud and on-premises enterprise software solutions that empower organizations to make smarter decisions based on advanced analytics of structured and unstructured data. NICE helps organizations of all sizes deliver better customer service, ensure compliance, combat fraud and safeguard citizens. Over 25,000 organizations in more than 150 countries, including over 85 of the Fortune 100 companies, are using NICE solutions. www.nice.com.
Trademark Note: NICE and the NICE logo are trademarks or registered trademarks of NICE Ltd. All other marks are trademarks of their respective owners. For a full list of NICE’s marks, please see: www.nice.com/nice-trademarks.
Forward-Looking Statements This press release contains forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Such forward-looking statements, including the statements by Mr. Eilam, are based on the current beliefs, expectations and assumptions of the management of NICE Ltd. (the "Company”). In some cases, such forward-looking statements can be identified by terms such as "believe,” "expect,” "seek,” "may,” "will,” "intend,” "should,” "project,” "anticipate,” "plan,” "estimate,” or similar words. Forward-looking statements are subject to a number of risks and uncertainties that could cause the actual results or performance of the Company to differ materially from those described herein, including but not limited to the impact of changes in economic and business conditions, including as a result of the COVID-19 pandemic; competition; successful execution of the Company’s growth strategy; success and growth of the Company’s cloud Software-as-a-Service business; changes in technology and market requirements; decline in demand for the Company's products; inability to timely develop and introduce new technologies, products and applications; difficulties or delays in absorbing and integrating acquired operations, products, technologies and personnel; loss of market share; an inability to maintain certain marketing and distribution arrangements; the Company’s dependency on third-party cloud computing platform providers, hosting facilities and service partners;, cyber security attacks or other security breaches against the Company; the effect of newly enacted or modified laws, regulation or standards on the Company and our products and various other factors and uncertainties discussed in our filings with the U.S. Securities and Exchange Commission (the "SEC”). For a more detailed description of the risk factors and uncertainties affecting the company, refer to the Company's reports filed from time to time with the SEC, including the Company’s Annual Report on Form 20-F. The forward-looking statements contained in this press release are made as of the date of this press release, and the Company undertakes no obligation to update or revise them, except as required by law.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200901005535/en/
Global climate innovator Trane Technologies (NYSE: TT) announced today the launch of its Center for Healthy and Efficient Spaces (CHES) to create safer, healthier, and more efficient environments for homes, buildings, and transportation around the globe. Rasha Hasaneen, Trane Technologies’ vice president of innovation and product excellence, will be the center’s director.
"Trane Technologies has been a leader in healthy and efficient indoor environments for decades. The global pandemic heightens sensitivity to the need for health and safety, and the overall quality of indoor environments. We are introducing CHES to focus on ensuring that homes, buildings, public transport and other spaces will come out of the pandemic healthier and more sustainable than ever,” said Hasaneen. "Through the center we are responding to urgent and increasing needs for solutions that reduce pathogens, mold, gases and other contaminants in the air we breathe and on the surfaces we touch.*
"Whether you’re at home, work, school, on a bus, or in a delivery vehicle, you want to feel safe and well. CHES will go beyond indoor air quality to consider all the factors that impact indoor environments – including lighting, acoustics and optimal temperatures and humidity. We are providing holistic and environmentally sound solutions. The center will take these outcomes to the next level by forming new partnerships, informing policies and standards, and accelerating innovation.”
Innovation and Policy Advocacy The CHES is working with technology and innovation companies in the climate sector to evaluate and scale the latest advancements in indoor environments across transport, homes, and a broad installed commercial buildings customer base. It will engage a global team of experts from the company’s commercial and residential HVAC and transport refrigeration businesses.
The center will work side-by-side with Trane Technologies’ Center for Energy Efficiency and Sustainability (CEES) to inform policy and standards that elevate indoor environmental quality. CEES is a council of global thought leaders in sustainability leadership, infrastructure development, energy policy, and technology that helps the company enact best practices in sustainability in the company and for its customers.
A Better, More Sustainable Normal "The new center will bring together world-leading expertise and technology inside and outside the company to address indoor environment challenges through and beyond the pandemic,” said Paul Camuti, Trane Technologies’ chief technology and strategy officer. "It will expand upon the comprehensive climate, refrigeration, and indoor air quality solutions we already deliver through our brands Trane® and Thermo King®. Together with our partners and customers we are building a new, better, more sustainable normal.”
Each indoor space is unique. Interactions between people and the systems that control any indoor environment they occupy, such as HVAC, lighting, and acoustics, are dynamic and complex. The company’s holistic approach includes assessing the indoor environment and recommendations to effectively mitigate and improve a space, whether it’s a home, building, or public transport vehicle.
Trane Technologies brings the most advanced solutions available for indoor air quality, ranging from building controls and filtration to air cleaning solutions and connected building solutions that adapt to the evolving needs of a building and its occupants. CHES is one more way the company continues to advance indoor environments as the world faces both a historic pandemic and a climate crisis.
Partnering with External Experts Trane Technologies has also established an Advisory Council on Healthy Spaces made up of leading experts who will support CHES goals with expertise in medicine, epidemiology, academic research, and policy, across building and transport sectors. Council members will advise on accelerating safer, healthier, and efficient environments in homes, buildings and transport, and on strategies to build resilience for businesses and communities.
In addition, Trane Technologies has become a founding keystone member of the International WELL Building Institute, whose mission is to improve human health and well-being in buildings. Holly Paeper, vice president of Trane’s Commercial HVAC business, will serve as an advisor on the WELL Health-Safety Rating for Sports and Entertainment Venues. Chris Hsieh, commercial applications engineer, will serve as an advisor on the WELL Health-Safety Rating for Facility Operations and Management.
For more information on the Center for Healthy and Efficient Spaces, click here.
*There is evidence from The American Society of Heating, Refrigerating, and Air-Conditioning Engineers (ASHRAE) and other sources that HVAC technologies can mitigate the risk of exposure to infectious aerosols in built environments; however, the transmission and mitigation of COVID-19 in buildings is yet to be tested and confirmed.
About Trane Technologies
Trane Technologies is a global climate innovator. Through our strategic brands Trane® and Thermo King®, and our portfolio of environmentally responsible products and services, we bring efficient and sustainable climate solutions to buildings, homes and transportation. Visit tranetechnologies.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200902005125/en/
SANTA CRUZ, Calif., Oct. 26, 2020 /PRNewswire/ -- A peer-reviewed study published in the research journal PLOS ONE demonstrates that MDMA-assisted psychotherapy is remarkably cost-effective when compared to currently available treatments for posttraumatic stress disorder (PTSD). It is estimated that public healthcare payers or private insurers making MDMA-assisted psychotherapy available to 1,000 patients would reduce general and mental health care costs by $103.2 million over 30 years.
Lead author Elliot Marseille, Dr.P.H., M.P.P., elaborates, "MDMA-assisted psychotherapy is conducted by a licensed psychologist and trained clinician over the course of twelve sessions. The cost is not inconsiderable, but in just over three years, healthcare providers will break even on the costs of mental health and general medical care. These estimates are promising yet likely too conservative: the study did not measure the value of increased productivity or lower disability payments as patients recover and is constrained by the limited data on the long-term trajectory of PTSD. Further research will be needed to determine the full financial, personal, and societal benefits of MDMA-assisted psychotherapy for PTSD."
Berra Yazar-Klosinski, Ph.D., Head of Research Development and Regulatory Affairs for MAPS Public Benefit Corporation and co-author, notes, "A growing body of evidence suggests that MDMA-assisted psychotherapy may be more effective than currently available treatments for PTSD, a notoriously difficult-to-treat condition. Previous research has focused on safety and efficacy and indicates statistically significant improvements over psychotherapy with a control, demonstrating reduction in symptoms for 82% of participants. This study should compel healthcare providers to include MDMA-assisted psychotherapy as a covered treatment for PTSD following FDA approval."
Rick Doblin, Ph.D., Executive Director of MAPS and a study co-author, states, "The profound personal toll of PTSD can include deterioration in physical health, relationships, and ability to participate in social activities along with the anxiety, insomnia, and suicidal ideation that mark the condition. By demonstrating a return of an average of 5.5 quality-adjusted life-years over 30 years, we have shown that MDMA-assisted psychotherapy has the potential to reduce more than the personal burden of PTSD, contributing to improved health outcomes and reduced healthcare burdens for payers and providers."
The cost-effectiveness of MDMA-assisted psychotherapy from the U.S. healthcare payers' perspective was constructed with a decision-analytic Markov model to portray the costs and health benefits of treating patients with chronic, severe, or extreme, treatment-resistant PTSD. Efficacy was based on the pooled results of six randomized controlled trials with the 105 subjects who participated in Phase 2 trials and a four-year follow-up of 19 of those subjects. The model calculates expected medical costs, mortality, quality-adjusted life-years, and incremental cost-effectiveness ratio over 30 years.
NOTEThe safety and efficacy of MDMA-assisted psychotherapy is currently under investigation. This treatment has not yet been approved by the FDA, does not work for everyone, and carries risks even in therapeutic settings.
DisclaimerThe news site hosting this press release is not associated with Multidisciplinary Association for Psychedelic Studies (MAPS). It is merely publishing a press release announcement submitted by a company, without any stated or implied endorsement of the treatment, product or service.
About Multidisciplinary Association for Psychedelic Studies
ABOUT MAPSFounded in 1986, MAPS is a 501(c)(3) non-profit research and educational organization that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics. Since its founding, MAPS has raised over $100 million for psychedelic therapy and medical research and education. For more information, visit maps.org.
ABOUT MAPS PUBLIC BENEFIT CORPORATION (MAPS PBC)MAPS Public Benefit Corporation (MAPS PBC) catalyzes healing and well-being through psychedelic drug development, therapist training programs, and sales of prescription psychedelics while prioritizing public benefit above profit. Founded in 2014, MAPS PBC is a wholly owned subsidiary of the Multidisciplinary Association for Psychedelic Studies (MAPS), a 501(c)(3) non-profit organization. More information about the organization is available at mapspublicbenefit.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/maps-study-mdma-assisted-psychotherapy-will-be-more-cost-effective-than-other-treatments-for-ptsd-301159940.html